Consensus review of the clinical utility of dna cytometry in carcinoma of the breast

Cytometry

Volumn 14, Issue 5, 1993, Pages 482-485

  Hedley, David W ^a   Clark, Gary M ^b   Cornelisse, Cees J ^e   Killander, Dick ^f   Kute, Timothy ^c   Merkel, Douglas ^d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d EVANSTON HOSPITAL   (United States)

^e LEIDEN UNIVERSITY   (Netherlands)

^f LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CONFERENCE PAPER; CYTOMETRY; DNA CONTENT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

BREAST NEOPLASMS; DNA, NEOPLASM; FLOW CYTOMETRY; GUIDELINES; HUMAN; PLOIDIES; PRACTICE GUIDELINES; PROGNOSIS; S PHASE;

EID: 0027217424     PISSN: 01964763     EISSN: 10970320     Source Type: Journal    
DOI: 10.1002/cyto.990140505     Document Type: Article

References (43)

1. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans
2. Comparative long‐term prognostic value of quantitative HER‐2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin‐embedded invasive breast cancer
3. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast
4. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer
5. DNA ploidy of primary breast cancer and local recurrence after breast‐conserving therapy
6. Prognostic significance of DNA‐ploidy in a series of 690 primary breast cancer patients
7. Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease‐free interval, female sex steroid receptors, ploidy and histological grading
8. Prognostic significance of S‐phase fraction in good‐risk, node‐negative breast cancer patients
9. Prediction of relapse or survival in patients with node‐negative breast cancer by DNA flow cytometry
10. DNA ploidy and survival in breast cancer patients
11. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival
12. Prognostic significance of the DNA content of human breast cancer
13. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer
14. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients
15. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors
16. Flow cytometric DNA index and S‐phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
17. One or multiple samplings for flow cytometric DNA analyses in breast cancer—prognostic implications?
18. DNA flow cytometric analysis of primary operable breast cancer: Relation of ploidy and S‐phase fraction to outcome of patients in NSABP B‐04
19. DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer:10 year results of a randomised study
20. Influence of Systematic Errors on the evaluation of the S Phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas
21. Association of DNA index and S‐phase fraction with prognosis of nodes positive early breast cancer
22. Association of over‐expression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node‐negative breast cancer patients
23. Improved prognostic impact of S‐phase values from paraffin‐embedded breast and prostate carcinomas after correcting for nuclear slicing
24. Inter‐laboratory comparison of DNA flow cytometric results from paraffin‐embedded breast carcinomas
25. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and s‐phase fraction: a proposed classification of DNA histograms in breast cancer
26. Aneuploid DNA content and high S‐phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer
27. Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma
28. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients
29. How reproducible are flow cytometry data from paraffin‐embedded blocks?
30. The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer
31. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast
32. Node‐negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry [see comments]
33. DNA index, S‐phase fraction, histological grade and prognosis in breast cancer
34. Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer
35. The prognostic significance of ploidy analysis in operable breast cancer
36. Indicators of prognosis in node‐negative breast cancer [see comments]
37. Flow cytometry in primary breast cancer: Improving the prognostic value of the fraction of cells in the S‐phase by optimal categorisation of cut‐off levels
38. Nuclear DNA content as a prognostic factor in T1‐2N0 breast cancer
39. The prognostic significance of nuclear DNA content in invasive breast cancer—a study with long‐term follow‐up
40. The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients
41. The importance of DNA flow cytometry in node‐negative breast cancer
42. DNA content flow cytometry as a prognostic factor for node‐positive breast cancer: The role of multiparameter ploidy analysis and specimen sonication